Skip to main content
17/09/2014

The series of conferences on Rare Diseases arrives at Madrid

2014_0189_IMATGE

17/09/2014

Dr. Llera's seminar is the first on the cicle to take place in Madrid, by now all had been in Barcelona

With Dr. Llera this Wednesday, September 17, resume the first series of conferences on rare diseases organized by the Vall d’Hebron Institute of Research (VHIR). Also, with this seminar, the cicle arrives at "http://www.fundacionareces.es/fundacionareces/" Madrid, as by now all have taken place in Barcelona.Dr. Llera’s conference, "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=82&RSS=" Optimizing the investigation processes on rare diseases and orphan drugs, is the seventh seminar programmed about rare diseases, and is 8 out of the 12 seminars that the Fundación Areces sponsors that will take place in Barcelona and Madrid, coinciding with the 20th anniversary of the Institute.The next seminar will be in Barcelona, on "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=148&RSS=" September 23, with Dr. Jordi Llinares, Head of Department-Product Development Scientific Support European Medicines Ageny, London (United Kingdom). And the next event in Madrid will be on October 29 with "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=85&RSS=" Dr. Ségolène Aymé, chair of the Topical Advisory Group for Rare Diseases Orphanet and director of the Insitut Nationale de la Santé et de la Recherche Médical (France).Until now, the hospital has hosted half of the seminars, with "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=78&RSS=" Dr. Ignacio Burgos, driver and coordinator of the rare diseases workshop at the Senate, "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=86&RSS=" Dr. Alastair Kent, director at the Genetic Alliance UK, "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=81&RSS=" Dr. Christoph Klein, Physician-in-Chief and Chairman at the Dr. von Hauner Children’s Hospital in Munich (Germany), "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=84&RSS=" Dr. Paul Lasko, Scientific Director at the Institute of Genetics of the Canadian Institutes of Health Research, and "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=83&RSS=" Prof. Danilo Tagle, program director for Neurogenetics at the National Institute of Neurological Disorders and Stroke at the University of Michigan (USA). Barcelona also hosted the opening session of the cicle, conducted by "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=en&mv1=4&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2014&num=37&RSS=" Manuel Posada, director of the rare diseases institute at Instituto de Salud Carlos III. More than 100 VHIR researchers study nearly 200 rare diseases from 26 different clinical areas. Besides, in the last 4 years, more than 230 clinical trials in these pathologies have been conducted at VHIR.

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.